ZANE TAYSIR HAMMOUD
Pharmacy in Northville, MI

License number
Michigan 5315035128
Issued Date
Mar 26, 2008
Expiration Date
Jan 31, 2018
Category
Pharmacy
Type
CS - 3
Address
Address
Northville, MI 48168

Personal information

See more information about ZANE TAYSIR HAMMOUD at radaris.com
Name
Address
Phone
Zane Hammoud, age 58
16108 Cog Hill Dr, Northville, MI 48168
(734) 404-5306
Zane Hammoud
23242 Beechcrest St, Dearborn Heights, MI 48127
Zane Hammoud
6524 Oakman Blvd, Dearborn, MI 48126
Zane Hammoud
Plymouth, MI
(734) 404-5306
Zane T Hammoud, age 58
16108 Cog Hill Dr, Northville, MI 48168
(734) 404-5306

Professional information

See more information about ZANE TAYSIR HAMMOUD at trustoria.com
Zane Hammoud Photo 1
Metabolite Biomarkers For The Detection Of Esophageal Cancer Using Nmr

Metabolite Biomarkers For The Detection Of Esophageal Cancer Using Nmr

US Patent:
2012014, Jun 7, 2012
Filed:
Sep 6, 2011
Appl. No.:
13/226256
Inventors:
M. Daniel Raftery - West Lafayette IN, US
Jian Zhang - West Lafayette IN, US
Zane Hammoud - Northville MI, US
Assignee:
Purdue Research Foundation - West Lafayette IN
International Classification:
C40B 30/00, C40B 40/12, C40B 40/04
US Classification:
506 7, 506 15, 506 19
Abstract:
Methods for the detection and screening of esophageal adenocarcinoma (EAC) patients and for the monitoring of EAC treatment using a panel or panels of small molecule metabolite biomarkers are disclosed. In other aspects, methods for detection and screening for the progression of high-risk conditions (BE and HOD) to EAC and to monitoring treatment using a panel or panels of small molecule metabolite biomarkers are disclosed. The biomarkers are sensitive and specific for the detection of EAC, and can also be used to classify Barrett's esophagus (BE) and high-grade dysplasia (HOD), which are widely regarded as precursors of EAC.


Zane Hammoud Photo 2
Metabolite Biomarkers For The Detection Of Esophageal Cancer Using Ms

Metabolite Biomarkers For The Detection Of Esophageal Cancer Using Ms

US Patent:
2012010, May 3, 2012
Filed:
Sep 6, 2011
Appl. No.:
13/226236
Inventors:
M. Daniel Raftery - West Lafayette IN, US
Danijel Djukovic - Indianapolis IN, US
Zane Hammoud - Northville MI, US
Assignee:
Purdue Research Foundation - West Lafayette IN
International Classification:
G01N 33/574, C07H 19/067, G01N 21/00, C07H 19/167
US Classification:
436501, 536 276, 536 2781, 536 285, 536 2853, 2524081
Abstract:
Results of studies of nucleosides in biofluid specimens from patients with esophageal adenocarcinoma and related disorders have identified five biomarkers of the conditions: 1-methyladenosine, N,N-dimethylguanosine, N-methylguanosine, cytidine and uridine. In certain embodiments, methods of measuring these biomarkers and kits for measuring these biomarkers are provided.